• Andy Y Wang, Jainith Patel, Matthew Kanter, Michelle Olmos, Mathew S Maurer, Ellen D McPhail, Ayan R Patel, Knarik Arkun, James Kryzanski, and Ron I Riesenburger.
• Department of Neurosurgery, Tufts Medical Center, Boston, Massachusetts, USA.
• World Neurosurg. 2023 Jun 16; 177: 889788-97.

AbstractSpinal stenosis is one of the most common neurosurgical diseases and a leading cause of pain and disability. Wild-type transthyretin amyloid (ATTRwt) has been found in the ligamentum flavum (LF) of a significant subset of patients with spinal stenosis who undergo decompression surgery. Histologic and biochemical analyses of LF specimens from spinal stenosis patients, normally discarded as waste, have the potential to help elucidate the underlying pathophysiology of spinal stenosis and possibly allow for medical treatment of stenosis and screening for other systemic diseases. In the present review, we discuss the utility of analyzing LF specimens after spinal stenosis surgery for ATTRwt deposits. Screening for ATTRwt amyloidosis cardiomyopathy through LF specimens has led to the early diagnosis and treatment of cardiac amyloidosis in several patients, with more expected to benefit from this process. Emerging evidence in the literature also point to ATTRwt as a contributor to a previously unrecognized subtype of spinal stenosis in patients who might, in the future, benefit from medical therapy. In the present report, we review the current literature regarding the early detection of ATTRwt cardiomyopathy via LF screening and the possible contribution of ATTRwt deposits in the LF to spinal stenosis development.Copyright © 2023 Elsevier Inc. All rights reserved.

4 keywords...

hide…